Previous 10 | Next 10 |
AnPac Bio-Medical Science Acquires GISN (HK) LIMITED, a Technical Solution and Outsourcing Consulting Services Provider PR Newswire NEW YORK , Feb. 15, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operati...
AnPac Bio-Medical Science (NASDAQ: ANPC) , a company with operations in the United States and China, and its subsidiary Foodbase Group Inc, have signed a definitive equity purchase agreement; the agreement outlines the acquisition of a group of affiliated companies: SLV Windfall Gr...
AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S. PR Newswire NEW YORK , Feb. 13, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a...
AnPac Bio-Medical Science (NASDAQ: ANPC) , a biotechnology company with operations in the United States and China focused on early cancer screening and detection and with plans to enter into the operation of a business-to-business (“B2B”) e-commerce food platform focused on the...
AnPac Bio-Medical Science ( NASDAQ: ANPC ) has announced that Co. through a subsidiary, Fresh2 Technology has entered into a definitive stock purchase agreement to acquire Fresh2 Ecommerce. This acquisition is a critical initiative for the Co.'s business strategy of entering into ...
AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce Platform PR Newswire Transaction expected to fuel the Company's growth in the U.S. food market NEW YORK , Feb. 9, 2023 /PRNewswire/...
AnPac Bio (NASDAQ: ANPC) , a biotechnology company with operations in the United States and China focused on early cancer screening and detection and a business-to-business (“B2B”) food e-commerce company, announced that in December 2022 and January 2023, the company signed definiti...
Biotechnology company, AnPac Bio-Medical Science ( NASDAQ: ANPC ) a nnounced that in December 2022 and January 2023, the Company signed definitive investment agreements with several third party investors. The investors agreed to purchase ~29.71M newly issued shares (...
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection and a business-to-business food e-commerce ...
Nasdaq has determined that the securities of the biotechnology company AnPac Bio-Medical Science ( NASDAQ: ANPC ) will delist over non compliance with the minimum $2.5M stockholders' equity requirement. The company now needs to timely request for a hearing before the Nasdaq Heari...
News, Short Squeeze, Breakout and More Instantly...
AnPac Bio-Medical Science Co. Ltd. Company Name:
ANPC Stock Symbol:
NASDAQ Market:
Fresh2 Group (NASDAQ: ANPC) , formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on th...
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' PR Newswire Ticker symbol change effective at the market open May 22, 2023 NEW YORK , May 19, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science...
Fresh2 Group Limited (NASDAQ: ANPC) , formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform foc...